219 related articles for article (PubMed ID: 23679870)
1. Stable RAGE-heparan sulfate complexes are essential for signal transduction.
Xu D; Young JH; Krahn JM; Song D; Corbett KD; Chazin WJ; Pedersen LC; Esko JD
ACS Chem Biol; 2013 Jul; 8(7):1611-20. PubMed ID: 23679870
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE.
Li M; Ong CY; Langouët-Astrié CJ; Tan L; Verma A; Yang Y; Zhang X; Shah DK; Schmidt EP; Xu D
Elife; 2022 Feb; 11():. PubMed ID: 35137686
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE).
Xu D; Young J; Song D; Esko JD
J Biol Chem; 2011 Dec; 286(48):41736-41744. PubMed ID: 21990362
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
5. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oligomerization of full-length RAGE by synergy of the interaction of its domains.
Moysa A; Hammerschmid D; Szczepanowski RH; Sobott F; Dadlez M
Sci Rep; 2019 Dec; 9(1):20332. PubMed ID: 31889156
[TBL] [Abstract][Full Text] [Related]
7. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
8. Targeting the heparan sulfate-binding site of RAGE with monoclonal antibodies.
Ong C; Li M; Xu D
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38181393
[TBL] [Abstract][Full Text] [Related]
9. Cysteine mediated disulfide bond formation in RAGE V domain facilitates its functionally relevant dimerization.
Jangde N; Ray R; Sinha S; Rana K; Singh SK; Khandagale P; Acharya N; Rai V
Biochimie; 2018 Nov; 154():55-61. PubMed ID: 30076903
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
Kim HJ; Jeong MS; Jang SB
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
[TBL] [Abstract][Full Text] [Related]
13. A model of full-length RAGE in complex with S100B.
Moysa A; Steczkiewicz K; Niedzialek D; Hammerschmid D; Zhukova L; Sobott F; Dadlez M
Structure; 2021 Sep; 29(9):989-1002.e6. PubMed ID: 33887170
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange.
Sitkiewicz E; Tarnowski K; Poznański J; Kulma M; Dadlez M
PLoS One; 2013; 8(10):e76353. PubMed ID: 24098480
[TBL] [Abstract][Full Text] [Related]
15. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
[TBL] [Abstract][Full Text] [Related]
16. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
18. RAGE Signaling in Melanoma Tumors.
Olaoba OT; Kadasah S; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
[TBL] [Abstract][Full Text] [Related]
19. Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes.
Serratos IN; Castellanos P; Pastor N; Millán-Pacheco C; Rembao D; Pérez-Montfort R; Cabrera N; Reyes-Espinosa F; Díaz-Garrido P; López-Macay A; Martínez-Flores K; López-Reyes A; Sánchez-García A; Cuevas E; Santamaria A
PLoS One; 2015; 10(3):e0120221. PubMed ID: 25757085
[TBL] [Abstract][Full Text] [Related]
20. RAGE signaling in inflammation and arterial aging.
Lin L; Park S; Lakatta EG
Front Biosci (Landmark Ed); 2009 Jan; 14(4):1403-13. PubMed ID: 19273137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
